Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study

Authors: Seung Jun Lee, Seung Hun Lee, You Eun Kim, Yu Ji Cho, Yi Yeong Jeong, Ho Cheol Kim, Jong Deog Lee, Jang Rak Kim, Young Sil Hwang, Hee Jin Kim, Dick Menzies

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

The diagnosis and treatment of latent tuberculosis infection (LTBI) have become mandatory to reduce the burden of tuberculosis worldwide. Close contacts of active TB patients are at high risk of both active and LTBI. The aim of this study is to identify the predominant risk factors of contracting LTBI, persons in close contact with TB patients were recruited. This study also aimed to compare the efficacy of the tuberculin skin test (TST) and QuantiFERON®-TB GOLD (QFT-G) to diagnose LTBI.

Methods

Close contacts of active pulmonary TB patients visiting a hospital in South Korea were diagnosed for LTBI using TST and/or QFT-G. The association of positive TST and/or QFT-G with the following factors was estimated: age, gender, history of Bacillius Calmette-Guerin (BCG) vaccination, history of pulmonary TB, cohabitation status, the acid-fast bacilli smear status, and presence of cough in source cases.

Results

Of 308 subjects, 38.0% (116/305) were TST positive and 28.6% (59/206) were QFT-G positive. TST positivity was significantly associated with male gender (OR: 1.734; 95% CI: 1.001-3.003, p =0.049), history of pulmonary TB (OR: 4.130; 95% CI: 1.441-11.835, p =0.008) and household contact (OR: 2.130; 95% CI: 1.198-3.786, p =0.01) after adjustment for confounding variables. The degree of concordance between TST and QFT-G was fair (70.4%, κ =0.392).

Conclusions

A prevalence of LTBI among close contacts of active pulmonary TB patients was high, and prior TB history and being a household contact were risk factors of LTBI in the study population.
Appendix
Available only for authorised users
Literature
2.
go back to reference The global plan to stop TB, 2006-2015: summary.Wkly Epidemiol Rec 2006, 81(9):86-88., The global plan to stop TB, 2006-2015: summary.Wkly Epidemiol Rec 2006, 81(9):86-88.,
3.
go back to reference Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec 2010, 85(9):69-80. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec 2010, 85(9):69-80.
4.
go back to reference Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR. 2010, 59 (RR-5): 1-25.PubMed Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR. 2010, 59 (RR-5): 1-25.PubMed
5.
go back to reference Moon H, Lee J: Korean Guidelines for Tuberculosis. 2011, Joint Committee for the Development of Korean Guidelines for Tuberculosis, Korea Moon H, Lee J: Korean Guidelines for Tuberculosis. 2011, Joint Committee for the Development of Korean Guidelines for Tuberculosis, Korea
6.
go back to reference Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent mycobacterium tuberculosis infection. JAMA. 2001, 286 (14): 1740-1747. 10.1001/jama.286.14.1740.CrossRefPubMed Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS: Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent mycobacterium tuberculosis infection. JAMA. 2001, 286 (14): 1740-1747. 10.1001/jama.286.14.1740.CrossRefPubMed
7.
go back to reference Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM: Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis. 2010, 14 (9): 1112-1119.PubMed Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM: Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis. 2010, 14 (9): 1112-1119.PubMed
8.
go back to reference El-Sadr WM, Tsiouris SJ: HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med. 2008, 29 (5): 525-531. 10.1055/s-0028-1085703.CrossRefPubMed El-Sadr WM, Tsiouris SJ: HIV-associated tuberculosis: diagnostic and treatment challenges. Semin Respir Crit Care Med. 2008, 29 (5): 525-531. 10.1055/s-0028-1085703.CrossRefPubMed
9.
go back to reference Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004, 170 (1): 65-69. 10.1164/rccm.200402-232OC.CrossRefPubMed Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med. 2004, 170 (1): 65-69. 10.1164/rccm.200402-232OC.CrossRefPubMed
10.
go back to reference Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170 (1): 59-64. 10.1164/rccm.200402-179OC.CrossRefPubMed Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004, 170 (1): 59-64. 10.1164/rccm.200402-179OC.CrossRefPubMed
11.
go back to reference Horsburgh CR, Rubin EJ: Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011, 364 (15): 1441-1448. 10.1056/NEJMcp1005750.CrossRefPubMed Horsburgh CR, Rubin EJ: Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med. 2011, 364 (15): 1441-1448. 10.1056/NEJMcp1005750.CrossRefPubMed
12.
go back to reference Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH: Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000, 162 (6): 2033-2038. 10.1164/ajrccm.162.6.2004022.CrossRefPubMed Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH: Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000, 162 (6): 2033-2038. 10.1164/ajrccm.162.6.2004022.CrossRefPubMed
13.
go back to reference Morrison J, Pai M, Hopewell PC: Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008, 8 (6): 359-368. 10.1016/S1473-3099(08)70071-9.CrossRefPubMed Morrison J, Pai M, Hopewell PC: Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2008, 8 (6): 359-368. 10.1016/S1473-3099(08)70071-9.CrossRefPubMed
14.
go back to reference Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A: Comparative performance of tuberculin skin test, QuantiFERON-TB-gold in tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest. 2009, 135 (4): 1010-1018. 10.1378/chest.08-2048.CrossRefPubMed Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A: Comparative performance of tuberculin skin test, QuantiFERON-TB-gold in tube assay, and T-Spot.TB test in contact investigations for tuberculosis. Chest. 2009, 135 (4): 1010-1018. 10.1378/chest.08-2048.CrossRefPubMed
15.
go back to reference Huang YW, Shen GH, Lee JJ, Yang WT: Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan. Int J Tuberc Lung Dis. 2010, 14 (11): 1430-1435.PubMed Huang YW, Shen GH, Lee JJ, Yang WT: Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan. Int J Tuberc Lung Dis. 2010, 14 (11): 1430-1435.PubMed
16.
go back to reference Jo KW, Hong Y, Park JS, Bae IG, Eom JS, Lee SR, Cho OH, Choo EJ, Heo JY, Woo JH, Shim TS: Prevalence of latent tuberculosis infection among health care workers in South Korea: a multicenter study. Tuber Respir Dis. 2013, 75 (1): 18-24. 10.4046/trd.2013.75.1.18.CrossRef Jo KW, Hong Y, Park JS, Bae IG, Eom JS, Lee SR, Cho OH, Choo EJ, Heo JY, Woo JH, Shim TS: Prevalence of latent tuberculosis infection among health care workers in South Korea: a multicenter study. Tuber Respir Dis. 2013, 75 (1): 18-24. 10.4046/trd.2013.75.1.18.CrossRef
17.
go back to reference Li J, Munsiff SS, Agerton TB: Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health. 2010, 12 (6): 816-822. 10.1007/s10903-008-9204-9.CrossRefPubMed Li J, Munsiff SS, Agerton TB: Prevalence of tuberculin skin test positivity in clinical population in New York City. J Immigr Minor Health. 2010, 12 (6): 816-822. 10.1007/s10903-008-9204-9.CrossRefPubMed
18.
go back to reference Pareek M, Bond M, Shorey J, Seneviratne S, Guy M, White P, Lalvani A, Kon OM: Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis. Thorax. 2013, 68 (3): 230-239. 10.1136/thoraxjnl-2011-201542.CrossRefPubMed Pareek M, Bond M, Shorey J, Seneviratne S, Guy M, White P, Lalvani A, Kon OM: Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis. Thorax. 2013, 68 (3): 230-239. 10.1136/thoraxjnl-2011-201542.CrossRefPubMed
19.
go back to reference Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H, Godfrey-Faussett P: Risk factors associated with positive QuantiFERON-TB gold in-tube and tuberculin skin tests results in Zambia and South Africa. PLoS One. 2011, 6 (4): e18206-10.1371/journal.pone.0018206.CrossRefPubMedPubMedCentral Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence KA, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H, Godfrey-Faussett P: Risk factors associated with positive QuantiFERON-TB gold in-tube and tuberculin skin tests results in Zambia and South Africa. PLoS One. 2011, 6 (4): e18206-10.1371/journal.pone.0018206.CrossRefPubMedPubMedCentral
20.
go back to reference Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM, Lange C: LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009, 33 (5): 956-973. 10.1183/09031936.00120908.CrossRefPubMed Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Holscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM, Lange C: LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J. 2009, 33 (5): 956-973. 10.1183/09031936.00120908.CrossRefPubMed
21.
go back to reference Kim HJ, Yoon HI, Park KU, Lee CT, Lee JH: The impact of previous tuberculosis history on T-SPOT.TB(R) interferon-gamma release assay results. Int J Tuberc Lung Dis. 2011, 15 (4): 510-516. 10.5588/ijtld.10.0520.CrossRefPubMed Kim HJ, Yoon HI, Park KU, Lee CT, Lee JH: The impact of previous tuberculosis history on T-SPOT.TB(R) interferon-gamma release assay results. Int J Tuberc Lung Dis. 2011, 15 (4): 510-516. 10.5588/ijtld.10.0520.CrossRefPubMed
22.
go back to reference Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV: Rapid detection of mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med. 2001, 163 (4): 824-828. 10.1164/ajrccm.163.4.2009100.CrossRefPubMed Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV: Rapid detection of mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med. 2001, 163 (4): 824-828. 10.1164/ajrccm.163.4.2009100.CrossRefPubMed
23.
go back to reference Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D: Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004, 38 (5): 754-756. 10.1086/381754.CrossRefPubMed Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D: Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004, 38 (5): 754-756. 10.1086/381754.CrossRefPubMed
24.
go back to reference Hu Y, Zhao Q, Graviss EA, Jiang W, Yuan Z, Xu B: Use of the T-SPOT.TB assay to screen latent tuberculosis infection among the TB contacts in Shanghai, China. J Infect. 2012, 65 (1): 39-48. 10.1016/j.jinf.2012.03.018.CrossRefPubMed Hu Y, Zhao Q, Graviss EA, Jiang W, Yuan Z, Xu B: Use of the T-SPOT.TB assay to screen latent tuberculosis infection among the TB contacts in Shanghai, China. J Infect. 2012, 65 (1): 39-48. 10.1016/j.jinf.2012.03.018.CrossRefPubMed
25.
go back to reference Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KP, Bennett S: Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in the Gambia. Am J Respir Crit Care Med. 2003, 168 (4): 448-455. 10.1164/rccm.200212-1483OC.CrossRefPubMed Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, Warndorff D, McAdam KP, Bennett S: Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in the Gambia. Am J Respir Crit Care Med. 2003, 168 (4): 448-455. 10.1164/rccm.200212-1483OC.CrossRefPubMed
26.
go back to reference Ozturk N, Surucuoglu S, Ozkutuk N, Gazi H, Akcali S, Koroglu G, Cicek C: Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts. Mikrobiyol Bul. 2007, 41 (2): 193-202.PubMed Ozturk N, Surucuoglu S, Ozkutuk N, Gazi H, Akcali S, Koroglu G, Cicek C: Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts. Mikrobiyol Bul. 2007, 41 (2): 193-202.PubMed
27.
go back to reference van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K: Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009, 180 (1): 49-58. 10.1164/rccm.200811-1704OC.CrossRefPubMed van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K: Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009, 180 (1): 49-58. 10.1164/rccm.200811-1704OC.CrossRefPubMed
Metadata
Title
Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study
Authors
Seung Jun Lee
Seung Hun Lee
You Eun Kim
Yu Ji Cho
Yi Yeong Jeong
Ho Cheol Kim
Jong Deog Lee
Jang Rak Kim
Young Sil Hwang
Hee Jin Kim
Dick Menzies
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0566-4

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.